论著

抗核抗体阳性类风湿关节炎的临床和实验室检查特点

  • 张警丰 ,
  • 叶修玲 ,
  • 段萌 ,
  • 周小利 ,
  • 姚中强 ,
  • 赵金霞
展开
  • 北京大学第三医院风湿免疫科,北京 100191

收稿日期: 2020-06-12

  网络出版日期: 2020-12-13

Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody

  • Jing-feng ZHANG ,
  • Xiu-ling YE ,
  • Meng DUAN ,
  • Xiao-li ZHOU ,
  • Zhong-qiang YAO ,
  • Jin-xia ZHAO
Expand
  • Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China

Received date: 2020-06-12

  Online published: 2020-12-13

摘要

目的:分析抗核抗体(anti-nuclear antibodies, ANA)阳性类风湿关节炎(rheumatoid arthritis,RA)患者的临床及实验室检查特征。方法:选择2013年1月—2018年12月于北京大学第三医院风湿免疫科住院的428例RA患者的临床及实验室检查资料,回顾性分析ANA阳性RA患者的临床和实验室检查指标的特点。统计学方法符合正态分布的定量资料采用t检验,非正态分布的定量资料采用Wilcoxon秩和检验。定性资料采用χ2检验,1≤理论频数<5采用校正四格表χ2检验,理论频数<1采用确切概率法。结果:收集到ANA阳性患者共231例(54%),ANA阳性组中女性占比明显多于ANA阴性组(82.7% vs. 63.5%, χ2=20.355,P<0.01);ANA阳性组出现跖趾关节受累(22.1%)低于ANA阴性组(33.0%, χ2=6.414,P<0.05),ANA阳性组中合并继发性干燥综合征(secondary Sj?gren’s syndrome, sSS)的比例显著高于ANA阴性组(19.5% vs. 4.1%, χ2=23.300,P<0.01);ANA阳性组合并类风湿因子(rheumatoid factor, RF)阳性(77.1% vs. 53.8%, χ2=25.743,P<0.01)及抗环瓜氨酸多肽(cyclic citrullinated peptide,CCP)抗体阳性(74.9% vs. 59.4%, χ2=11.694,P<0.01)的比例均显著高于阴性组。ANA阳性组免疫球蛋白G(immunoglobulin G,IgG)水平[(15.1±5.1) g/L vs. (13.8±5.3) g/L, t=2.359, P<0.05]及免疫球蛋白M(immunoglobulin M,IgM)水平[1.25(0.92) g/L vs.1.05(0.65) g/L, Z=-3.449, P<0.01]高于阴性组,而血红蛋白(hemoglobin, Hb)水平[(109.64±17.98) vs. (114.47±18.48) g/L,t=-2.734, P<0.01]、血小板(platelet, PLT)水平[(266.4×109±104.6×109) vs. (295.9×109±100.1×109) /L,t=-2.970, P<0.01]低于阴性组。结论:ANA阳性RA患者合并sSS的比例显著高于ANA阴性者,前者IgG水平更高,而Hb及PLT水平则更低。

本文引用格式

张警丰 , 叶修玲 , 段萌 , 周小利 , 姚中强 , 赵金霞 . 抗核抗体阳性类风湿关节炎的临床和实验室检查特点[J]. 北京大学学报(医学版), 2020 , 52(6) : 1023 -1028 . DOI: 10.19723/j.issn.1671-167X.2020.06.006

Abstract

Objective: To analyse the clinical and laboratory characteristics of antinuclear antibody (ANA) positive rheumatoid arthritis (RA) patients. Methods: The clinical and laboratory data of 428 RA cases from Department of of Rheumatology and Immunology Peking University Third Hospital from Jan 2013 to Dec 2018 were collected and used to analyse characters between ANA positive group and ANA negative group. T test was used for the quantitative data in accordance with normal distribution. Wilcoxon rank sum test was used for the quantitative data of non normal distribution. The qualitative data were analyzed by chi square test. But while 1≤theoretical frequency<5, chi square test of corrected four grid table was used. And Fisher exact probability method was used when theoretical frequency<1. Results: The number of ANA positive group was 231 (54%). The female rate was obviously higher in ANA positive group (82.7% vs. 63.5%, χ2=20.355,P<0.01). The rate of metatarsophalangeal joints (MTPJs) involvement was lower in ANA positive group (22.1%) than in ANA negative group (33.0) (χ2=6.414, P<0.05). The incidence of secondary Sj?gren’s syndrome (sSS) was much higher in ANA positive group(19.5% vs. 4.1%, χ2=23.300,P<0.01). The positivity of rheumatoid factor (RF), as well as the positivity of anti-cyclic citrullinated peptide(CCP) antibody was much higher in ANA positive group (77.1% vs. 53.8%, χ2=25.743,P<0.01, 74.9% vs. 59.4%, χ2=11.694,P<0.01, respectively). The levels of immunoglobulin G (IgG) and immunoglobulin M (IgM) of ANA positive group were higher [(15.1±5.1) g/L vs. (13.8±5.3) g/L, t=2.359, P<0.05, 1.25 (0.92) g/L vs. 1.05 (0.65) g/L, Z=-3.449, P<0.01, respectively]. But the levels of hemoglobin (Hb) and platelet (PLT) was lower in ANA positive group[ (109.64±17.98) vs. (114.47±18.48) g/L,t=-2.734, P<0.01; (266.4×109±104.6×109) vs. (295.9×109±100.1×109) /L,t=-2.970, P<0.01, respectively]. Conclusion: The incidence of sSS was obviously higher in ANA positive group than in ANA negative group. Serum IgG of ANA positive group was higher, but Hb and PLT were lower.

参考文献

[1] Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the anti-nuclear antibody test and tests for specific autoantibodies to nuclear antigens[J]. Arch Pathol Lab Med, 2000,124(1):71-81.
[2] Nishimura S, Nishiya K, Hisakawa N, et al. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis[J]. Acta Medica Okayama, 1996,50(5):261-265.
[3] Torre IG, Mendez LM. Studies of antinuclear antibodies in rheumatoid arthritis[J]. J Rheumatol, 1982,9(4):603-606.
[4] Aitcheson CT, Peebles C, Joslin F, et al. Characteristics of antinuclear antibodies in rheumatoid arthritis[J]. Arthritis Rheum, 1980,23(5):528-538.
[5] Marques RC, Bogas M, Ramos F, et al. Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review[J]. Acta Reumatol Port, 2014,39(2):116-122.
[6] Hügle B, Hinze C, Lainka E, et al. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course[J]. Pediatr Rheumatol, 2014,12(1):28.
[7] Fernandez SAV, Lobo AZC, Oliveira ZNP, et al. Prevalence of antinuclear autoantibodies in the serum of normal blood donors[J]. Rev Hosp Clin, 2003,58(6):315-319.
[8] Racoubian E, Zubaid RM, Shareefd MA, et al. Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008-2015: a cross-sectional study involving 10 814 subjects[J]. Rheumatol Int, 2016,36(9):1231-1236.
[9] Bienenstock H. Rheumatoid plantar synovial cysts[J]. Ann Rheum Dis, 1975,34(1):98-99.
[10] Antero DC, Parra AGM, Miyazaki FH, et al. Secondary Sj?gren’s syndrome and disease activity of rheumatoid arthritis[J]. Rev Assoc Méd Bras(English Edition), 2011,57(3):313-316.
[11] Al-Osami MH, Allawi AAM, Al-Saadawi TH. The association of smoking with the extra-articular manifestations in rheumatoid arthritis patients[J]. Postgrad Med J, 2013,12(1):146-152.
[12] Kuller LH, Mackey RH, Walitt BT, et al. Rheumatoid arthritis in the women health initiative: methods and baseline evaluation[J]. Am J Epidemiol, 2014,179(7):917-926.
[13] Tellides G, Pober JS. Inflammatory and immune responses in the arterial media[J]. Circ Res, 2015,116(2):312-322.
[14] Aghdashi MA, Khadir M, Dinparasti-Saleh R. Antinuclear antibodies and lupus-like manifestations in rheumatoid arthritis and ankylosing spondylitis patients at 4 months’ follow-up after treatment with infliximab and etanercept[J]. Curr Rheumatol Rev, 2020,16(1):61-66.
[15] Yukawa N, Fujii T, Ishikawa SK, et al. Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study[J]. Arthritis Res Ther, 2011,13(6):R213.
文章导航

/